Sclerosis multiplex (SM): vizsgálatok itt: Dél-afrikai Köztársaság

2 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  Where

  Cape Town, Pretoria

  Életkor

  40 év to 70 év

  People

  400 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06846281 · EU 2023-509275-17-00
• 3. fázisTaking people
  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Where

  Cape Town

  Életkor

  18 év to 65 év

  People

  1275 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07225504